* Veracyte Inc VCYT.OQ VCYT.O is expected to show a rise in
quarterly revenue when it reports results on July 29.
* The South San Francisco, California-based company is expected
to report a 132.1% increase in revenue to $48.062 million from
$20.7 million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Veracyte Inc is for a
loss of 25 cents per share. For the same quarter last year, the
company reported a loss of 22 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Veracyte Inc is
$55, about 32.4% above its last closing price of $37.20.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.12 -0.12 -0.11 Beat 8.3
Dec. 31 2020 -0.10 -0.11 -0.14 Missed -30.2
Sep. 30 2020 -0.20 -0.21 -0.08 Beat 61.9
Jun. 30 2020 -0.27 -0.24 -0.22 Beat 9.8
Mar. -0.19 -0.20 -0.24 Missed -22
31 2020
Dec. 31 2019 -0.07 -0.07 -0.15 Missed -100
Sep. 30 2019 -0.07 -0.07 -0.02 Beat 72.7
Jun. 30 2019 -0.09 -0.10 -0.05 Beat 49
This summary was machine generated July 27 at 21:33 GMT. All
figures in US dollars unless otherwise stated